Valuation: Precipio, Inc.

Market Cap 41.97M 36.88M 34.28M 31.52M 59.11M 4.05B 60.24M 409M 160M 1.99B 157M 154M 6.88B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 42.97M 37.76M 35.09M 32.27M 60.52M 4.15B 61.67M 419M 163M 2.03B 161M 158M 7.04B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.41%
Yield 2024 *
-
Yield 2025 -
1 day-2.56%
1 week-9.35%
Current month-7.59%
1 month-1.57%
3 months-18.26%
6 months-6.15%
Current year-0.44%
1 week 22.51
Extreme 22.51
24.75
1 month 22
Extreme 22
27.13
Current year 19.52
Extreme 19.52
33.63
1 year 13.8
Extreme 13.8
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 2017-05-31
Chief Executive Officer 54 2017-06-27
Director TitleAgeSince
Director/Board Member 54 2017-06-27
Director/Board Member 78 2017-09-25
Director/Board Member 67 2017-11-07
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Director

416 0.0233%
7/15/26 Free

Director

520 0.0291%
7/15/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-9.35%+65.80%+252.00% 41.97M
+0.23%-10.35%+15.85%-36.63% 15.8B
+9.95%+3.06%+10.99%+115.26% 1.63B
-0.60%-9.05%-35.08%-80.94% 1.14B
-4.66%-5.73%-37.45%+10.63% 1.01B
+0.57%-4.41%-30.13%-53.93% 627M
+2.48%-7.99%-46.66%-56.93% 505M
+0.56%-0.65%+41.42%-53.79% 449M
-2.94%-6.16%-55.92%-62.88% 372M
-2.25%+2.66%-19.47%-39.30% 350M
Average +0.08%-1.79%-9.06%-0.65% 2.19B
Weighted average by Cap. +0.65%-7.21%+6.48%-26.73%

Financials

2024 2025
Net sales 18.53M 16.29M 15.14M 13.92M 26.1M 1.79B 26.6M 181M 70.45M 877M 69.54M 68.06M 3.04B 24.05M 21.13M 19.64M 18.06M 33.87M 2.32B 34.52M 235M 91.42M 1.14B 90.24M 88.32M 3.94B
Net income -4.29M -3.77M -3.5M -3.22M -6.04M -414M -6.16M -41.84M -16.31M -203M -16.1M -15.76M -703M -363K -319K -296K -273K -511K -35.05M -521K -3.54M -1.38M -17.18M -1.36M -1.33M -59.47M
Net Debt -136K -120K -111K -102K -192K -13.13M -195K -1.33M -517K -6.44M -510K -499K -22.28M 1M 881K 818K 753K 1.41M 96.76M 1.44M 9.77M 3.81M 47.41M 3.76M 3.68M 164M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
26-07-23 US$22.88 -2.56% 94,205
26-07-22 US$23.48 -0.93% 254,918
26-07-21 US$23.70 +1.28% 85,145
26-07-20 US$23.40 -5.03% 109,126
26-07-17 US$24.64 +4.05% 108,324
  1. Stock Market
  2. Stocks
  3. PRPO Stock